When the CPS worker investigated us in our home this year, she ended her interrogation of me by asking me if I had any questions. I did. Quite a few, actually. Like "How do you sleep at night" and "Show me in the Constitution where any of this is legal." Buckle up. Angry 🧵:

Dose dense chemotherapy benifit after 15 years follow up . 5 % improvement in OS for Hr positive and 13 % OS improvements for Hr - ve . No role of 5 Flurouracil in adjuvant chemo for breast . ESMO - Eur. Oncology OncoAlert #ESMO22

#ESMO22 Exciting data by Sapna Patel SWOG Cancer Research Network 1801- neoadjuvant > adjuvant pembro in resectable stage 3-4 melanoma, and few AEs ESMO - Eur. Oncology OncoAlert

Time toxicity of cancer treatment by Dr Booth. Very Important concept .Oncologist must take this into consideration bhawna sirohi ecancer Bishal Gyawali, MD, PhD, FASCO Richard Sullivan #choosingwisely2022

Later lines of treatment for metastatic CRC. What would you choose? Here an overview of the most important therapy strategies. OncoAlert Oncology Brothers

"Pancreatic Adenocarcinoma Management" An excellent review that briefly summarizes all treatment lines. Thanks to the authors. JCO Oncology Practice ASCO #MedTwitter ascopubs.org/doi/full/10.12…

How to choose the right treatment for patients w/ mHSPC? Expert Christopher Sweeney, MBBS gives us everything we need to make up our minds

Aaron Goodman - “Papa Heme” How do I know this? Thanks to Dr Fulcher.

Treatment of mCRC: ASCO Guideline 🔹Anti-EGFR with triplet ChT is not recommended 🔹CRS may be recommended for selected pts with PM 🔸HIPEC is not recommended 🔹SBRT may be recommended for pts with oligometastases of the liver... Journal of Clinical Oncology OncoAlert ascopubs.org/doi/abs/10.120…

Sid Yadav MD, FACP Got this today from Paolo Tarantino A lot more than I thought. Moderately Emetigenic in NCCN category

With Amyloidosis Support talking about #amyloidosis therapy this morning Mayo Clinic - lots of new stuff to discuss!

The hardest #top10 (ish) I’ve ever done for a meeting: the amount of critical data that will be presented at #SABCS22 is impressive. Novel drugs, important trial updates, highly awaited biomarker data, new paradigms. Make sure not to miss what promises to be a remarkable SABCS!

How’s studying for #hematology boards going, you ask? My notes, as a thoracic oncologist ✍️: 🍿: Nodular Lymphocyte Predominant HL 🌸🍀: Adult T cell Leukemia 🧲: Anaplastic Large Cell Lymphoma 🌌: Burkitt Lymphoma 🦉 👀 : Hodgkin Lymphoma Did I do you proud, Aaron Goodman - “Papa Heme”?

New review on state-of-the-art treatment of advanced phase #CML (AP/BP) by @JayastuMD and @NicholasShort of MD Anderson Cancer Center #Leukemia, published in Leukemia Journal. We prefer ponatinib-based combo regimens for these pts whenever possible. rdcu.be/cZBFa #leusm

Every day Mark Cuban Cost Plus Drug Company uncovers generic drugs that are insanely priced. If there is a generic that you can not afford , or that is charged for hundreds or thousands of dollars to your employer's insurance, please reply with the name and we will see if we can source it. Thanks

Hepatitis B can be cured Hepatitis C can be cured Fatty liver disease is reversible Cirrhosis can be reversed Paracetamol doesn't cause chronic liver damage Liver can't be detoxed Alcohol use disorder is a chronic disease Whey protein doesn't damage liver Listen to real doctors.

#SABCS22 is about to start! So much data to be presented! Breast Cancer OncoAlert

Well deserved award! A leader by example - thank you for being so kind to those around you (particularly your trainees). Congratulations!

What will we do Monday morning? My take home points from #SABCS22 - limiting and oversimplifying an incredible amount of high-quality research to fit in a few slides OncoAlert #bcsm SABCS

Just what everyone wants: an epic Super Bowl decided in the end by the refs